Tetramer staining for endogenous tumor-associated gp70 demonstrated a significant 2-fold increase in gp70+/CD8+ T-cells when PEF was added to systemic therapies (cisplatin + αPD-1) relative to systemic therapies alone (Fig 3A). Here, CD8A is linked to neoplasm.